Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Policy Changes In Part D Could Improve Patients’ Rx Adherence, Professor Argues

Executive Summary

Former MedPAC member Bruce Stuart offers policy recommendations that would make medication therapy management programs in the Medicare Part D more effective, with the goal of improving medication adherence.

You may also be interested in...



Medication Therapy Management To Expand In Part D Under CMS Rule

CMS expects the proposed changes to medication therapy management will make 55% of Medicare beneficiaries eligible for MTM services, which CMS says has been shown to improve drug therapy outcomes and reduce health care costs.

A Personal Touch Can Help Medication Adherence, Mass General Finds

As themes of patient-centered outcomes and personalized medicine become more common in drug development, the concepts also are playing out in the medication adherence space, as shown in a program at Massachusetts General Hospital.

Pharmacists, HIT Can Be Key To Successful Rx Care In ACO Model

The Marshfield Clinic in Wisconsin shows how pharmacists and health information technology can be incorporated into an accountable care organization’s pharmaceutical care in a way that can help improve patient outcomes and influence prescribing behavior.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS054848

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel